MEDIPOST Co., Ltd. (KOSDAQ:078160)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,260.00
+170.00 (2.10%)
Nov 2, 2026, 3:30 PM KST

MEDIPOST Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
74,84473,65770,65768,64364,20154,856
Revenue Growth
3.70%4.25%2.93%6.92%17.03%12.81%
Gross Profit
47,80045,43644,13840,18438,37331,863
Operating Income
-76,452-68,023-48,552-25,263-17,434-5,724
Net Income
-23,076-85,398-62,5255,8403,069-683.26
Earnings Per Share
-1382.32-2408.00-1834.00231.00165.00-43.00
EPS Growth
---40.00%--

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Health Function Food Sector
10,71410,4178,8529,5529,8819,707
Others
9,6275,5125,7897,6795,6472,203
Cell Therapy Sales Division
18,73319,46120,29721,74019,63117,233
Adjustment and Removal
-7,252-3,231-3,456-3,021-472.62-58.76
Cord Blood Division
40,08941,49939,17632,69429,51425,773
Total
74,84473,65770,65768,64364,20154,856

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
193,47178,03493,200159,555123,62157,654
Total Debt
160,04840,39911,15211,64349,51829,844
Net Cash (Debt)
33,42337,63482,048147,91274,10327,810
Net Cash Growth
-20.42%-54.13%-44.53%99.60%166.46%68.96%
Net Cash Per Share
880.521061.172406.175844.043988.571731.42

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-58,047-57,146-37,266-19,078-5,3504,056
Capital Expenditures
-4,682-2,915-2,666-2,560-3,227-10,175
Free Cash Flow
-62,729-60,061-39,932-21,638-8,577-6,119
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
63.87%61.69%62.47%58.54%59.77%58.08%
Operating Margin
-102.15%-92.35%-68.72%-36.80%-27.16%-10.44%
Pretax Margin
-40.89%-116.59%-89.07%6.43%10.14%1.10%
Profit Margin
-30.83%-115.94%-88.49%8.51%4.78%-1.25%
FCF Margin
-83.81%-81.54%-56.52%-31.52%-13.36%-11.15%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
---47.6578.40-
Forward PE
-196.40196.40196.40196.40196.40
PS Ratio
4.229.655.564.053.756.30